# US 2004/0081701 A1 · Hydrolyzed cellulose granulations of partial salts of drugs

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2004/0081701 A1
- Document ID: US20040081701A1
- Status: Published application
- Kind: A1
- Application number: 10/457,270
- Filed: 2003-06-09
- Published: 2004-04-29
- Earliest claimed: 1999-09-29
- Inventors: David F. Erkoboni; Ronald S. Vladyka JR.; Christopher A. Sweriduk; Andrew J. Favara
- Web page: https://patentgrep.com/patent/US20040081701A1

## CPC

- A61K 9/1652: {Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin (homeopathic globules A61K9/1623)}
- A61K 9/2054: {Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose}
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)

## Abstract

The present invention provides a method for preparing a spray-dried, compressible granular formulation for preparing pharmaceutical tablets in which essentially water-insoluble, acidic, amphoteric, and basic pharmaceutically active agents are converted to more water-soluble salts which are granulated with hydrolyzed cellulose, drug-containing slurries, the resulting granulations, capsules containing granulations, and pharmaceutical tablets compressed from such granules. In these formulations there is employed from 1% to 85% by weight of the pharmaceutically active agent in its salt form, from 5% to 99% of hydrolyzed cellulose, based on the dry weight of the granulation, and optionally, conventional granulation and/or tableting additives such as surfactants, disintegrants, and antiadherents/flow aids. Said tablets have significantly increased dissolution of the pharmaceutically active agent at the pH of the gastrointestinal tract in comparison with the unconverted free pharmaceutically active agent.

## Claims

### Claim 1

A method of improving dissolution of a relatively water-insoluble pharmaceutically active agent comprising the steps of:
a) mixing hydrolyzed cellulose with a water of hydration of 30 to 90% with at least one relatively water-insoluble pharmaceutically active agent, and an acid or base that is capable of reacting with said relatively water-insoluble pharmaceutically active agent in an aqueous solvent to form a salt, the amount of said acid or base being sufficient to convert at least 5% but less than 100% of said relatively water-insoluble pharmaceutically active agent to said salt, to form a mixture; and
b) drying the mixture to form granules.

### Claim 2

A dry granular composition comprising hydrolyzed cellulose in immixture with at least one relatively water-insoluble pharmaceutically active agent in its more water-soluble form wherein said pharmaceutically active agent in its more water-soluble salt form comprises about 30% to about 80% of said composition and comprises a mixture of ibuprofen and its potassium salt in a ratio of about 3:1 to 1:1; said hydrolyzed cellulose comprises about 20% to about 70% of said composition; said composition additionally comprising about 1% to about 10% of croscarmellose sodium, about 0.5% to about 5% of colloidial silicon dioxide, and about 0.05% to about 0.4% sodium lauryl sulfate; all percentages being by weight of the dry granules.

### Claim 3 (depends on 1)

The method according to claim 1 wherein said relatively water-insoluble active agent is ibuprofen, ketoprofen, or naproxen.

### Claim 4 (depends on 3)

The method according to claim 3 wherein said relatively water-insoluble pharmaceutically active agent is ibuprofen.

### Claim 5 (depends on 1)

The method according to claim 1 wherein said mixture comprises at least about 10% to about 60% solids by weight.

### Claim 6 (depends on 1)

The method according to claim 1 wherein said granules comprise at least about 97.5% solids by weight.

### Claim 7 (depends on 1)

The product of the method of claim 1.

### Claim 8 (depends on 7)

A product according to claim 7 that comprises more than 97.5% solids by weight.

### Claim 9 (depends on 7)

A product according to claim 7 wherein said granules comprise:
a) about 1% to about 95% by weight of said salt; and
b) about 5% to about 99% by weight of said hydrolyzed cellulose.

### Claim 10 (depends on 9)

A product according to claim 9 wherein said granules are substantially porous and substantially spherical.

### Claim 11 (depends on 10)

A compressed pharmaceutical tablet comprising the product according to claim 10.

### Claim 12

The method of improving dissolution of a relatively water-insoluble pharmaceutically active agent comprising the steps of:
a) mixing hydrolyzed cellulose with a water of hydration of 30-90% with at least one relatively water-insoluble pharmaceutically active agent, and an acid or base that is capable of reacting with said relative water-insoluble pharmaceutically active agent to form a salt, the amount of said acid or base being insufficient to convert 100% of said relatively water-insoluble pharmaceutically active agent to said salt, to form a mixture; and
b) drying the mixture to form granules.

### Claim 13 (depends on 12)

The method according to claim 12 wherein said relatively water-insoluble pharmaceutically active agent is ibuprofen, ketoprofen, or naproxen.

### Claim 14 (depends on 12)

The method according to claim 12 wherein said mixture comprises at least about 10% to about 60% solids by weight.

### Claim 15 (depends on 12)

The method according to claim 12 wherein said granules comprise at least about 97.5% solids by weight.

### Claim 16 (depends on 12)

The product of the method of claim 12.

### Claim 17 (depends on 16)

A product according to claim 16 that comprises more than 97.5% solids by weight.
